Published in Am J Psychiatry on December 01, 2004
Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics | NCT03220776
A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry (2009) 1.84
Anxiety and outcome in bipolar disorder. Am J Psychiatry (2009) 1.13
Sleep functioning in relation to mood, function, and quality of life at entry to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord (2008) 1.11
Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci (2013) 1.08
Patterns of comorbidity among mental disorders: a person-centered approach. Compr Psychiatry (2010) 1.04
Differential diagnosis of bipolar disorder in children and adolescents. World Psychiatry (2012) 1.03
BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol Psychiatry (2011) 1.02
Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD. Am J Psychiatry (2014) 0.97
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2016) 0.96
Brief intervention for anxiety in primary care patients. J Am Board Fam Med (2009) 0.96
Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders. J Psychiatr Res (2007) 0.95
Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates. J Clin Psychiatry (2010) 0.94
A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric Population. EBioMedicine (2015) 0.90
Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar I disorder. Bipolar Disord (2007) 0.90
Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population. J Psychiatr Res (2012) 0.90
Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder. J Affect Disord (2008) 0.90
Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol (2008) 0.89
Functional outcome in bipolar disorder: the big picture. Depress Res Treat (2011) 0.89
Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disorders. J Clin Psychiatry (2011) 0.87
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. Expert Rev Neurother (2009) 0.87
Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials. J Clin Psychiatry (2008) 0.86
Clinical features of bipolar disorder comorbid with anxiety disorders differ between men and women. Depress Anxiety (2012) 0.86
Impulsivity, anxiety, and alcohol misuse in bipolar disorder comorbid with eating disorders. Int J Bipolar Disord (2013) 0.86
Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry (2011) 0.86
Predictors of bipolar disorder risk among patients currently treated for major depression. MedGenMed (2006) 0.85
Management of treatment-resistant panic disorder. Psychiatry (Edgmont) (2007) 0.85
Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study. Bipolar Disord (2009) 0.84
Misdiagnosis of bipolar disorder. Psychiatry (Edgmont) (2006) 0.84
Medical and substance-related comorbidity in bipolar disorder: translational research and treatment opportunities. Dialogues Clin Neurosci (2008) 0.84
Anxiety in children with mood disorders: a treatment help or hindrance? J Abnorm Child Psychol (2012) 0.83
Posttraumatic stress disorder, depression, and health-related quality of life in patients with bipolar disorder: review and new data from a multi-site community clinic sample. J Affect Disord (2012) 0.83
Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord (2011) 0.83
Daily longitudinal self-monitoring of mood variability in bipolar disorder and borderline personality disorder. J Affect Disord (2016) 0.83
A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disord (2009) 0.83
Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. Transl Psychiatry (2016) 0.82
Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients. Int J Clin Pract (2010) 0.82
Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality? Bipolar Disord (2008) 0.82
Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. Am J Addict (2010) 0.82
Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders. Transl Psychiatry (2015) 0.81
The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic. Neuropsychiatr Dis Treat (2007) 0.81
Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms. J Affect Disord (2014) 0.81
Attentional bias in euthymic bipolar I disorder. Cogn Emot (2015) 0.80
Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord (2012) 0.80
Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches. World J Psychiatry (2015) 0.80
Number of prior episodes and the presence of depressive symptoms are associated with longer length of stay for patients with acute manic episodes. Ann Gen Psychiatry (2012) 0.80
Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2006) 0.80
Comorbid bipolar disorder and obsessive-compulsive disorder. Shanghai Arch Psychiatry (2015) 0.80
Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China. PLoS One (2014) 0.80
The temporal course and clinical correlates of subjective impulsivity in bipolar disorder as revealed through ecological momentary assessment. J Affect Disord (2015) 0.80
Co-morbidity in Bipolar Disorder: A Retrospective Study. Indian J Psychol Med (2014) 0.79
Correlates of historical suicide attempt in rapid-cycling bipolar disorder: a cross-sectional assessment. J Clin Psychiatry (2009) 0.79
Association between illicit drug and alcohol use and first manic episode. Pharmacol Biochem Behav (2006) 0.78
Quality of life in bipolar type I disorder in a one-year followup. Depress Res Treat (2012) 0.78
A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder. Clin Neuropharmacol (2011) 0.78
Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series. Behav Modif (2012) 0.78
Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin Neurosci (2015) 0.78
Identifying a clinical signature of suicidality among patients with mood disorders: A pilot study using a machine learning approach. J Affect Disord (2016) 0.77
Quetiapine monotherapy for bipolar depression. Neuropsychiatr Dis Treat (2008) 0.77
Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies. Prim Care Companion J Clin Psychiatry (2009) 0.77
Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders. J Am Acad Child Adolesc Psychiatry (2013) 0.77
The influence of comorbid disorders on the episodicity of bipolar disorder in youth. Acta Psychiatr Scand (2015) 0.77
Anxiety disorders in bipolar I mania: prevalence, effect on illness severity, and treatment implications. Indian J Psychol Med (2013) 0.77
A cross-species genetic analysis identifies candidate genes for mouse anxiety and human bipolar disorder. Front Behav Neurosci (2015) 0.76
Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry. Neuropsychiatr Dis Treat (2014) 0.76
Threat sensitivity in bipolar disorder. J Abnorm Psychol (2015) 0.76
Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder. Bipolar Disord (2008) 0.76
What Did We Learn from Research on Comorbidity In Psychiatry? Advantages and Limitations in the Forthcoming DSM-V Era. Clin Pract Epidemiol Ment Health (2012) 0.76
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood. PLoS One (2016) 0.76
Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. Eur Psychiatry (2013) 0.76
Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord (2017) 0.75
Symptom severity of bipolar disorder during the menopausal transition. Int J Bipolar Disord (2015) 0.75
Use of health care services by patients with co-occurring severe mental illness and substance use disorders. Ment Health Subst Use (2008) 0.75
Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort. Mol Psychiatry (2016) 0.75
Are anxiety disorders associated with a more severe form of bipolar disorder in adolescents? Indian J Psychiatry (2011) 0.75
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors. Ann Gen Psychiatry (2015) 0.75
Eye Tracking of Attention to Emotion in Bipolar I Disorder: Links to Emotion Regulation and Anxiety Comorbidity. Int J Cogn Ther (2016) 0.75
What and who? Mindfulness in the mental health setting. BJPsych Bull (2016) 0.75
Physical Exercise for Treatment of Mood Disorders: A Critical Review. Curr Behav Neurosci Rep (2016) 0.75
Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian J Psychiatry (2017) 0.75
Self-referential thinking, suicide, and function of the cortical midline structures and striatum in mood disorders: possible implications for treatment studies of mindfulness-based interventions for bipolar depression. Depress Res Treat (2011) 0.75
Dysfunctional gaze processing in bipolar disorder. Neuroimage Clin (2017) 0.75
Clinical Insight Into Latent Variables of Psychiatric Questionnaires for Mood Symptom Self-Assessment. JMIR Ment Health (2017) 0.75
A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use. Psychopharmacology (Berl) (2017) 0.75
Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial. J Affect Disord (2017) 0.75
Simplifying profiles of comorbidity in bipolar disorder. J Affect Disord (2017) 0.75
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry (2003) 13.60
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61
Surgery versus nonsurgical treatment of lumbar spinal stenosis: a randomized trial. Ann Intern Med (2015) 6.66
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA (2006) 6.26
A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry (2008) 6.24
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med (2006) 6.00
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet (2003) 5.75
Medication augmentation after the failure of SSRIs for depression. N Engl J Med (2006) 5.16
Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry (2006) 4.37
Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol (2013) 4.20
Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry (2002) 4.08
Moderators of treatment outcomes: clinical, research, and policy importance. JAMA (2006) 4.03
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry (2006) 3.90
The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2008) 3.82
Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80
Development of a computerized adaptive test for depression. Arch Gen Psychiatry (2012) 3.77
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry (2006) 3.70
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol (2008) 3.65
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2004) 3.43
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry (2011) 3.34
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry (2014) 3.27
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry (2005) 3.23
Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry (2005) 3.19
Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry (2005) 3.05
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry (2005) 3.03
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol (2007) 2.99
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry (2006) 2.90
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry (2006) 2.85
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry (2007) 2.84
The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry (2014) 2.82
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77
Improving clinical trials: American Society of Clinical Psychopharmacology recommendations. Arch Gen Psychiatry (2002) 2.70
Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry (2006) 2.69
Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatr Serv (2008) 2.68
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet (2006) 2.55
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2009) 2.39
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27
Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry (2008) 2.25